Lyka Labs
LYKALABS · Pharma > Pharmaceuticals & Drugs · Chairman: Kunal N Gandhi · MD: Kunal N Gandhi · Listing date: Feb. 8, 1995 · Employees: 99 · Mumbai · http://www.lykalabs.com

Stock Price vs Company Growth
1d
1.6%
1w
1.4%
1m
2.9%
3m
7.2%
6m
28.4%
1y
7.8%
5y
52.1%
10y
18.1%
all
6.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 141 1.6%
122
173
Company Overview

Sales
132 Cr
Growth: 8.5%
Profit after Tax
3.17 Cr
Growth: 443.1%
Small Cap
503 Cr
P/S: 3.8x
Industry P/S: 3.1x
Fundamentals

Sales (Cr) ₹ 132
Growth 8.5%
EBITDA 13.3%
P/S 3.8x
Dividend 0.0%
P/E -60.7x
Book Value ₹ 20.8
PEG Ratio -7.1x
ROE 4.8%
P/B 6.8x
Shareholding Pattern

Institutions
Cobra India (Mauritius) Limited
3.5 %
Promoters
Narendra Ishwarlal Gandhi Huf
4.88 %
Narendra Ishwarlal Gandhi
4.07 %
Nehal Narendra Gandhi
3.99 %
Kunal Narendra Gandhi
3.51 %
Enai Trading And Investment Pvt.Ltd.
3.42 %
Others
Mayank Jashwantlal Shah
6.98 %
Shruti Mayank Shah
5.3 %
Prasham Mayank Shah
5.23 %
Amee Parikh
3.4 %
Dalal & Broacha Stock Broking Pvt.Ltd.
2.79 %
Increase    Decrease    No change
Company Profile Detailed

Lyka Labs Ltd was incorporated on December 29, 1976 as a private limited company and converted into a public limited company on December 19, 1985.The company is engaged in the manufacture of pharmaceutical products. It also manufactures Veterinary products including injections, powders, creams and suspensions. The company offers various surgical disposables, such as syringes, surgical blades, cotton crepe bandage and first aid kits.
Investors (62)
Followers (3)